Boyd Rutten

Boyd Rutten has made 55 investments in companies such as: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation, Breath Therapeutics, Roche Glycart, Innate Pharma, Inova Labs, Moximed, Nightbalance, Eargo, Inari Medical, STAT-Dx, VerzuimVitaal, Ascendis Pharma, SANIFIT, BG Medicine, Prosonix, Nyxoah, Draupnir Bio, Axonics Modulation Technologies, Levicept, Big Health, Calypso Biotech, NIZO, Chroma Therapeutics, Pieris AG, LUMICKS, Ablative Solutions, Symphogen, MTM Laboratories, Definiens, Fysius Rugexperts, Agendia, Vesper Medical, Galapagos, Lumeon, Pharmaline, Volta Medical, Amphista Therapeutics, Withings, Novicare, ProFibrix, Ablynx, Conatus Pharmaceuticals, Zetacom, BionX™ Medical Technologies, Acacia Pharma, CVRx, Lava Therapeutics, Stepping Stones Home & Care, Evotec, Vapotherm, FlowCardia, FIRE1.

Location of Boyd Rutten is Utrecht, The Netherlands.

The free version of Angel Match provides limited data for Boyd Rutten. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Boyd Rutten is a Investment Manager and he his investment types are: Private Equity Firm, Venture Capital.
Boyd Rutten focuses investing in industries such as: Biotechnology, Life Science, Medical Device, Biopharma, Artificial Intelligence, Health Care, Software, Medical, Compliance, Hospital, Audio, Wearables, Apps, Consumer Electronics, Wellness, Health Diagnostics.

A short brief about investor:


Past investments

Social media:

Available after registration.